Complex relationships of nicotinic receptor actions and cognitive functions

Effects of nicotine administration on spectral and temporal features of crystallized song in the adult male zebra finch

INTRODUCTION

The process through which the zebra finch (Taeniopygia guttata) acquires and produces crystallized song has long been thought of as highly analogous to the process through which humans acquire and produce speech. Nicotinic acetylcholine receptors are present in song nuclei that play important roles in song production and/or acquisition. We studied the effect of in vivo nicotine on temporal and spectral features of crystallized song.

METHODS

We used 16 adult male zebra finches that were exposed to an established 7-day nicotine or saline treatment. Song behavior was monitored for a 2-month period following the cessation of the nicotine/saline treatment. All animals served as their own control in order to determine whether any song characteristics changed over the observed time period compared to the baseline measurement.

RESULTS

Inter-syllable duration and Wiener entropy were significantly affected by the in vivo administration of nicotine. These observed changes persisted for a 2-month period following the cessation of nicotine exposure. Similar changes were not observed in the age-matching control group.

CONCLUSIONS

Nicotine significantly affected tempo and rhythm of the crystallized zebra finch song. We believe that this in vivo nicotine-exposed zebra finch model can not only provide a further understanding of the underlying behavioral mechanisms of the cognitive implications of nicotine dependence but also help in the development of therapeutics targeting cognitive deficits often observed during nicotine withdrawal.

Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal

INTRODUCTION

Current FDA-approved smoking cessation pharmacotherapies have limited efficacy and are associated with high rates of relapse. Therefore, there is a clear need to develop novel antismoking medications. Nicotine withdrawal is associated with cognitive impairments that predict smoking relapse. It has been proposed that these cognitive deficits are a hallmark of nicotine withdrawal that could be targeted in order to prevent smoking relapse. Thus, pharmacotherapies that increase cognitive performance during nicotine withdrawal may represent potential smoking cessation agents.

AREAS COVERED

The authors review the clinical literature demonstrating that nicotine withdrawal is associated with deficits in working memory, attention and response inhibition. They then briefly summarize different classes of compounds and strategies to increase cognitive performance during nicotine withdrawal. Particular emphasis has been placed on translational research in order to highlight areas for which there is strong rationale for pilot clinical trials of potential smoking cessation medications.

EXPERT OPINION

There is emerging evidence that supports deficits in cognitive function as a plausible nicotine withdrawal phenotype. The authors furthermore believe that the translational paradigms presented here may represent efficient and valid means for the evaluation of cognitive-enhancing medications as possible treatments for nicotine dependence.

Nicotinic modulation of cortical circuits

The ascending cholinergic neuromodulatory system sends projections throughout cortex and has been shown to play an important role in a number of cognitive functions including arousal, working memory, and attention. However, despite a wealth of behavioral and anatomical data, understanding how cholinergic synapses modulate cortical function has been limited by the inability to selectively activate cholinergic axons. Now, with the development of optogenetic tools and cell-type specific Cre-driver mouse lines, it has become possible to stimulate cholinergic axons from the basal forebrain (BF) and probe cholinergic synapses in the cortex for the first time. Here we review recent work studying the cell-type specificity of nicotinic signaling in the cortex, synaptic mechanisms mediating cholinergic transmission, and the potential functional role of nicotinic modulation.